P877: IXAZOMIB DARATUMUMAB AND LOW‐DOSE DEXAMETHASONE IN INTERMEDIATE‐FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA; RESULTS OF THE INDUCTION AND MAINTENANCE TREATMENT OF THE... by Groen, Kaz, Stege, Claudia, Nasserinejad, Kazem, Heer, Koen, Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka‐Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie‐Christiane, Donk, Niels W.C.J., Timmers, Gert‐Jan, Boer, Fransien, Tick, Lidwine W., Spek, Ellen, Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., Levin, Mark‐David, Ypma, Paula F., Zweegman, Sonja

Get full text

Elotuzumab, lenalidomide, and dexamethasone in RRMM: final overall survival results from the phase 3 randomized ELOQUENT-2 study by Dimopoulos, Meletios A., Lonial, Sagar, White, Darrell, Moreau, Philippe, Weisel, Katja, San-Miguel, Jesus, Shpilberg, Ofer, Grosicki, Sebastian, Špička, Ivan, Walter-Croneck, Adam, Magen, Hila, Mateos, Maria-Victoria, Belch, Andrew, Reece, Donna, Beksac, Meral, Spencer, Andrew, Oakervee, Heather, Orlowski, Robert Z., Taniwaki, Masafumi, Röllig, Christoph, Einsele, Hermann, Matsumoto, Morio, Wu, Ka Lung, Anderson, Kenneth C., Jou, Ying-Ming, Ganetsky, Alex, Singhal, Anil K., Richardson, Paul G.

Get full text

Concurrent ibrutinib plus venetoclax in relapsed/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study by Wang, Michael, Ramchandren, Radhakrishnan, Chen, Robert, Karlin, Lionel, Chong, Geoffrey, Jurczak, Wojciech, Wu, Ka Lung, Bishton, Mark, Collins, Graham P, Eliadis, Paul, Peyrade, Frédéric, Lee, Yihua, Eckert, Karl, Neuenburg, Jutta K, Tam, Constantine S

Get full text

Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial by Minnema, Monique C, Nasserinejad, Kazem, Hazenberg, Bouke, Hegenbart, Ute, Vlummens, Philip, Ypma, Paula F, Kröger, Nicolaus, Wu, Ka Lung, Kersten, Marie Jose, Schaafsma, M Ron, Croockewit, Sandra, de Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemieke, Koene, Harry, Bos, Gerard, Sonneveld, Pieter, Schönland, Stefan

Get full text

Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial by Groen, Kaz, Stege, Claudia A.M., Nasserinejad, Kazem, de Heer, Koen, van Kampen, Roel J.W., Leys, Rineke B.L., Thielen, Noortje, Westerman, Matthijs, Wu, Ka-Lung, Ludwig, Inge, Issa, Djamila E., Velders, Gerjo A., Vekemans, Marie-Christiane, Timmers, Gert-Jan, de Boer, Fransien, Tick, Lidwine W., Verbrugge, Annelies, Buitenhuis, Danny, Cunha, Sonia M., van der Spek, Ellen, de Waal, Esther G.M., Sohne, Maaike, Sonneveld, Pieter, Nijhof, Inger S., Klein, Saskia K., van de Donk, Niels W.C.J., Levin, Mark-David, Ypma, Paula F., Zweegman, Sonja

Get full text

HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients by Minnema, Monique C., Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula F., Wu, Ka Lung, Kersten, Marie Jose, Croockewit, Sandra, Zweegman, Sonja, Tick, Lidwine, Broijl, Annemiek, Koene, Harry, Bos, Gerard M. J., Sonneveld, Pieter, Schönland, Stefan O.

Get full text

S197: LINKER‐MM1 STUDY: LINVOSELTAMAB (REGN5458) IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA by Lee, Hans C., Bumma, Naresh, Richter, Joshua, Dhodapkar, Madhav, Hoffman, James E., Suvannasankha, Attaya, Zonder, Jeffrey, Shah, Mansi R., Lentzsch, Suzanne, Maly, Joseph J., Ye, Jing Christine, Wu, Ka Lung, Deveaux, Michelle, Chokshi, Dhruti, Boyapati, Anita, Hazra, Anasuya, Lorenc, Karen Rodriguez, Kroog, Glenn, Houvras, Yariv, Jagannath, Sundar

Get full text

Massilia timonae Infection Presenting as Generalized Lymphadenopathy in a Man Returning to Belgium from Nigeria by Van Craenenbroeck, Amaryllis H, Camps, Kim, Zachee, Pierre, Wu, Ka Lung

Get full text

P899: HOVON 104; LONG TERM FOLLOW‐UP OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER BORTEZOMIB INDUCTION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED AL AMYLOIDOSIS by Minnema, Monique, Nasserinejad, Kazem, Hegenbart, Ute, Ypma, Paula, Lung Wu, Ka, José Kersten, Marie, Croockewit, Sandra, Waal, Esther, Zweegman, Sonja, Tick, Lidwien, Broijl, Annemiek, Schönland, Stefan

Get full text

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a rand... by Attal, Michel, Richardson, Paul G, Rajkumar, S Vincent, San-Miguel, Jesus, Spicka, Ivan, Leleu, Xavier, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A, Huang, Jeffrey Shang-Yi, Cavo, Michele, Prince, H Miles, Campana, Frank, Dubin, Franck, Attal, Michel, Rajkumar, Vincent, San-Miguel, Jesus, Beksac, Meral, Spicka, Ivan, Schjesvold, Fredrik, Moreau, Philippe, Dimopoulos, Meletios A., Minarik, Jiri, Cavo, Michele, Prince, H. Miles, Macé, Sandrine, Le-Guennec, Solenn, Dubin, Franck, Anderson, Kenneth C., Harrison, Simon, Janowski, Wojt, Kerridge, Ian, Delforge, Michel, Fostier, Karel, Vlummens, Philip, Wu, Ka Lung, Leblanc, Richard, Pavic, Michel, Sebag, Michael, Hajek, Roman, Maisnar, Vladimir, Gregersen, Henrik, Benbouker, Lotfi, Caillot, Denis, Facon, Thierry, Karlin, Lionel, Kolb, Brigitte, Pegourie, Brigitte, Tiab, Mourad, Vincent, Laure, Niederwieser, Dietger, Anagnostopoulos, Achilles, Delimpasi, Sosana, Symeonidis, Anargyros, Illes, Arpad, Mikala, Gabor, Corradini, Paolo, Fabio, Ciceri, Lemoli, Roberto, Liberati, Anna, Zambello, Renato, Iida, Shinsuke, Ikeda, Takashi, Iyama, Satoshi, Matsumoto, Morio, Sunami, Kazutaka, Suzuki, Kenshi, Uchiyama, Michihiro, Koh, Youngil, Kim, Kihyun, Lee, Jae Hoon, Min, Chang-Ki, Blacklock, Hillary, Goodman, Hugh, Neylon, Annette, Simpson, David, Grosicki, Sebastian, Jurczyszyn, Artur, Walter-Croneck, Adam, Araujo, Luis, Moreira, Claudia, Doronin, Vadim, Vranovsky, Andrej, Alegre, Adrian, Gonzalez Perez, Marta Sonia, Montes, Carmen, Ocio, Enrique, Rodriguez, Paula, Hardling, Mats, Lauri, Birgitta, Wang, Ming-Chung, Yeh, Su-Peng, Arat, Mutlu, Gulbas, Zafer, Karadogan, Ihsan, Tuglular, Tulin, Vural, Filiz, Sive, Jonathan, Yong, Kwee, Tache, Jason

Get full text

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicent... by Dimopoulos, Meletios A, Prof, Moreau, Philippe, Prof, Palumbo, Antonio, Prof, Joshua, Douglas, Prof, Pour, Ludek, Prof, Hájek, Roman, Prof, Facon, Thierry, Prof, Ludwig, Heinz, Prof, Oriol, Albert, Prof, Goldschmidt, Hartmut, Prof, Rosiñol, Laura, Prof, Straub, Jan, Prof, Suvorov, Aleksandr, Prof, Araujo, Carla, Prof, Rimashevskaya, Elena, Prof, Pika, Tomas, Prof, Gaidano, Gianluca, Prof, Weisel, Katja, Prof, Goranova-Marinova, Vesselina, Prof, Schwarer, Anthony, Prof, Minuk, Leonard, Prof, Masszi, Tamás, Prof, Karamanesht, Ievgenii, Prof, Offidani, Massimo, Prof, Hungria, Vania, Prof, Spencer, Andrew, Prof, Orlowski, Robert Z, MD, Gillenwater, Heidi H, MD, Mohamed, Nehal, PhD, Feng, Shibao, PhD, Chng, Wee-Joo, Prof

Get full text

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial by Gay, Francesca, Weisel, Katja Christina, Goldschmidt, Hartmut, Maisnar, Vladimir, Moreau, Philippe, Pluta, Agnieszka, Chng, Wee-Joo, Kaiser, Martin, Zweegman, Sonja, Spencer, Andrew, Skacel, Tomas, Palumbo, Antonio, Labotka, Richard, Fantl, Dorotea, Horvath, Neomi, Lee, Cindy, Taylor, Kerry, Spencer, Andrew, Agis, Hermine, Zojer, Niklas, Offner, Fritz, Wu, Ka Lung, Zanella, Karla, Capra, Marcelo, Araújo, Sérgio, Gregora, Evzen, Hajek, Roman, Maisnar, Vladimir, Scudla, Vlastimil, Spicka, Ivan, Abildgaard, Niels, Andersen, Niels, Jensen, Bo Amdi, Plesner, Torben, Salomo, Morten, Svirskaite, Asta, Moreau, Philippe, Goldschmidt, Hartmut, Schieferdecker, Aneta, Zeis, Matthias, Klein, Stefan, Reimer, Peter, Hoffmann, Martin, Kyrtsonis, Mary-Christine, Anagnostopoulos, Achilleas, Illés, Árpád, Borbényi, Zita, Mikala, Gabor, Dally, Najib, Horowitz, Netanel, Gutwein, Odit, Nemets, Anatoly, Vaxman, Iuliana, Trestman, Svetlana, Preis, Meir, Rossi, Giuseppe, Liberati, Anna Marina, Bosi, Alberto, Nakaseko, Chiaki, Matsumoto, Morio, Nagai, Hirokazu, Sunami, Kazutaka, Chou, Takaaki, Akashi, Koichi, Eom, Hyeon Seok, Min, Chang Ki, Yoon, Sung Soo, Kim, Kihyun, Vellenga, Edo, Grosicki, Sebastian, Pluta, Andrzej, Robak, Tadeusz, Bergantim, Rui, Goh, Yeow Tee, McDonald, Andrew, Rapoport, Bernado, Álvarez Rivas, Miguel Angel, De Arriba de La Fuente, Felipe, Mateos, Maria Victoria, Oriol Rocafiguera, Albert, San Miguel, Jesús, Alegre-Amor, Adrian, Axelsson, Per, Carlson, Kristina, Stromberg, Olga, Hansson, Markus, Liu, Ta-Chih, Huang, Shang-Yi, Unal, Ali, Goker, Hakan, Sonmez, Mehmet, Korenkova, Sybiryna, Oakervee, Heather, Sati, Hamdi, Benjamin, Reuben, Garg, Mamta, Cook, Gordon, Jenner, Matthew, Berryman, Robert, Janakiram, Murali

Get full text

A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B‐cell lymphoma by Coiffier, Bertrand, Radford, John, Bosly, André, Martinelli, Giovanni, Barca, Gabriela, Davies, Andrew, Decaudin, Didier, Gallop‐Evans, Eve, Padmanabhan‐Iyer, Swaminathan, Eygen, Koen, Wu, Ka Lung, Gupta, Ira V., Lin, Thomas S., Goldstein, Nancy, Jewell, Roxanne C., Winter, Paul, Lisby, Steen

Get full text

Single Centre Retrospective Analysis: Transformation of Waldenström’s Macroglobulinemia to Diffuse Large B-Cell Lymphoma by Heyrman, Bert, Granacher, Nikki, Wu, Ka Lung

Get full text

Pleomorphic presentation of cutaneous lesions associated with the proteasome inhibitor bortezomib in patients with multiple myeloma by Wu, Ka Lung, Heule, Freerk, Lam, King, Sonneveld, Pieter

Get full text

Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma,... by Thomas, Sheeba K., Suvorov, Alexander, Noens, Lucien, Rukavitsin, Oleg, Fay, Joseph, Wu, Ka Lung, Zimmerman, Todd M., van de Velde, Helgi, Bandekar, Rajesh, Puchalski, Thomas A., Qi, Ming, Uhlar, Clarissa, Samoylova, Olga S.

Get full text

Abnormalities of chromosome 1p/q are highly associated with chromosome 13/13q deletions and are an adverse prognostic factor for the outcome of high‐dose chemotherapy in patients w... by Wu, Ka Lung, Beverloo, Berna, Lokhorst, Henk M., Segeren, Christine M., Van Der Holt, Bronno, Steijaert, Monique M., Westveer, Petra H., Poddighe, Pino J., Verhoef, Gregor E., Sonneveld, Pieter

Get full text

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 tria... by Dimopoulos, Meletios A, Terpos, Evangelos, Boccadoro, Mario, Delimpasi, Sosana, Beksac, Meral, Katodritou, Eirini, Moreau, Philippe, Baldini, Luca, Symeonidis, Argiris, Bila, Jelena, Oriol, Albert, Mateos, Maria-Victoria, Einsele, Hermann, Orfanidis, Ioannis, Ahmadi, Tahamtan, Ukropec, Jon, Kampfenkel, Tobias, Schecter, Jordan M, Qiu, Yanping, Amin, Himal, Vermeulen, Jessica, Carson, Robin, Sonneveld, Pieter, Alegre Amor, Adrian, Baldini, Luca, Beksac, Meral, Belotti, Angelo, Benboubker, Lotfi, Besemer, Britta, Besisik, Sevgi, Bila, Jelena, Boccadoro, Mario, Cavo, Michele, De La Rubia Comos, Javier, Delimpasi, Sosana, Dimopoulos, Meletios A., Doyen, Chantal, Dytfeld, Dominik, Engelhardt, Monika, Facon, Thierry, Foà, Roberto, Goldschmidt, Hartmut, Grosicki, Sebastian, Hajek, Roman, Hayri Ozsan, Guner, Hulin, Cyrille, Iversen, Brian, Karlin, Lionel, Katodritou, Eirini, Knop, Stefan, Kyrtsonis, Marie-Christine, Lahuerta, Juan Jose, Leleu, Xavier, Martinez Chamorro, Carmen, Mateos Manteca, María-Victoria, Meuleman, Nathalie, Minnema, Monique, Moreau, Philippe, Offidani, Massino, Oriol Rocafiguera, Albert, Pehlivan, Mustafa, Pour, Ludek, Roerdink, Henk Th.J., Rosinol Dacsh, Laura, Salwender, Hans, Sonneveld, Pieter, Symeonidis, Anargyros, Toftmann Hansen, Charlotte, Tuglular, Tulin, Unal, Ali, Vlummens, Philip, Vural, Filiz, Wu, Ka Lung, Zweegman, Sonja

Get full text

A randomized, open‐label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus flu... by Awan, Farrukh T., Hillmen, Peter, Hellmann, Andrzej, Robak, Tadeusz, Hughes, Steven G., Trone, Denise, Shannon, Megan, Flinn, Ian W., Byrd, John C.

Get full text

Phase II multicenter study of arsenic trioxide, ascorbic acid and dexamethasone in patients with relapsed or refractory multiple myeloma by Wu, KL, Beksac, M, van Droogenbroeck, J, Amadori, S, Zweegman, S, Sonneveld, P

Get full text